chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling like crap after both of his Moderna Covid-19 vaccinations) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling like crap after both of his Moderna Covid-19 vaccinations). At the time of the report, FEELING ABNORMAL (Feeling like crap after both of his Moderna Covid-19 vaccinations) outcome was unknown. No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-400040 (Patient Link).
From 6-48 hours after: chills, headache, hot flashes, fever of 100.5 On 4/12/2021 I had to call an ambulance due to issues with vision including seeing weird color patterns and near black out along with racing heart and lightheadedness.  I refused further medical care because I felt better once the ambulance arrived. I visited my primary care doctor on 4/13/2021 to follow up.  He said it was likely an occular migraine.  A blood test was ordered and results came back as essentially normal.  I have been continuing to have dizzy spells, headaches, blurry vision and light sensitivity. An MRI of my  brain and spinal cord has been ordered for 4/29 to rule out other conditions.
patient had flu like symptoms and a sore arm, more than with any other immunization he has had, for about a week after the shot.  He has continued to have chills since the time of vaccination with no resolution.
Patient received ZOSTAVAX on 09/06/13. On Sunday 09/08/13 fiance reported taking him to the ER at 9 PM Saturday 09/07/13 complaining of trouble breathing, dizziness, vomiting and frontal headache. Heart attack was ruled out - possible reaction to ZOSTAVAX. On Sunday 09/08/13 - a half dollar size rash appears at injection site - his primary doctor calls in Meclizine and Promethazide for nausea and dizziness.
Red, rash like. Pt. stated he did vomit on 9/22/2010.
ADMISSION: 12262021: co illness x 1.5 weeks. sts "it feels like when I had DKA", abd pain n/v, unable to eat since Thursday, this is 3rd MD visit since illness onset, on Mon began abx for shortness of breath, cough, BA, chills, fatigue, & fever. Denies increased urine output. Presents to the emergency department today for nausea, vomiting, fever, and generalized abdominal discomfort.  Patient is a type 2 diabetic controlled on multiple medications, initially metformin for years, then oral and eventually added insulin a year or two ago.  He states a week and a half ago he had URI symptoms and tested COVID negative, got a Zpak from his PCP last Monday. Cough has persisted and fatigue. Felt weak today and felt "like when I had DKA before" and came back to the ED. On room air, COVID swab positive, lab not c/w DKA but dry and hyperglycemic. States had Johnson and Johnson vaccine last March and has not gotten booster because "I'm sick every time I think about making an appointment to get it". DISCHARGE: 12272021: no discharge instructions posted at this time.
Patient developed symptoms of MISC on 2/23/22; fevers began on 2/24/22 with a Tmax of 40.6 degrees Celsius. Over the course of illness, symptoms and complications included fevers, sinus tachycardia, shortness of breath, abdominal pain, vomiting, mucocutaneous lesions/conjunctivitis, headache, near syncope, neck pain, myalgias, and cervical lymphadenopathy. Abnormal labs included elevated NT-ProBNP, thrombocytopenia, elevated AST, elevated CRP, and elevated ferritin. ECHO studies were normal. Patient was admitted to the hospital on 2/28/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 3/3/22. He was readmitted on 3/3/22 and treated with a second dose of infliximab; he was discharged on 3/5/2022.
This spontaneous report was received from a Licensed Practical Nurse concerning to two patients of unknown ages and genders. The patients' concurrent conditions, medical history and historical drugs were not reported. On 13-JUL-2017, the patients were administered improperly stored VARIVAX lot number M041080, expiration date 06-OCT-2018 (dose and route were not reported) for prophylaxis. Concomitant medication included sterile diluent. The temperature involved was from 15 to 46 grades Fahrenheit for 9 hours. A previous temperature excursion was not reported, and a data logger was involved.
no adverse effects, pt gwas given Dtap but it should have been Tdap as pt is older than 6 years old. She was behind on her vaccines and had not received her 5th dose of dtap prior to this date
Patient presented for second dose of Moderna on 3/17/2022. He received a 0.5ml dose of Moderna in right deltoid. Afterward it was discovered he had received his first dose of Moderna on 3/4/2022, making the interval between doses too close. Patient received a repeat second dose of Moderna on 4/14/2022 per CDC guidelines.
Patient had localized reaction. Raised bumpy center with redness surrounding entire administration area. Instructed patient to contact physician for follow up and that this may occur due to her own tolerability.
hearing loss; other zoster-related conditions; other zoster-related conditions; Information has been received on 04-JAN-2021 from a lawyer regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On an unknown date in 2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. On unknown dates, subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by healthcare providers at hearing aid centers for hearing loss and other zoster-related conditions. As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events was considered to be not recovered/not resolved. The reporter considered the events of hearing loss and other zoster-related conditions to be related to zoster vaccine live (ZOSTAVAX).  Upon internal evaluation, the event of hearing loss was determined to be medically significant.
soreness in arm approximately 4 hours after injecting; patient left work early due to feeling ill after the vaccine; This is a spontaneous report from a contactable consumer. An adult male patient received first dose of bnt162b2 (BNT162B2), lot number not reported, via an unspecified route of administration from an unspecified date as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient described soreness in arm approximately 4 hours after injecting. The following day, the patient left work early due to feeling ill after the vaccine. This was his first vaccination in the covid-19 series. The outcome of the events was recovered. No treatment was given for the events. The patient did not have COVID-19 prior vaccination. It was unknown if the patient has been tested for COVID-19 post vaccination.  Information on the lot/batch number has been requested.
Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Biontech and Biontech. Past adverse reactions to the above products included No adverse event with Biontech and Biontech.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported. No treatment medications was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Mom called and stated that pt's left arm was swollen with redness extending to pt's back shoulder blade. Was seeing allergist today for another reason. Would speak to allergist if DTaP reaction.
Patient developed a flushing sensation and was warm on the forehead.  She also felt warmth at the injection site (right arm).  Symptoms occurred right at 15 minutes of observation.  Patient also felt slight tightness in her chest.  Blood pressure was 160/91, pulse 72, SaO2 was 98% on room air.  Patient observed for an additional 15 minutes after diphenhydramine administered.  Patient also given cool pack for back of neck.  No hives or itching were noted.
Patient received FLUZONE HD vaccine on Thurs. 10/11/12 and reported a rash from her shoulder to elbow. Rash developed Friday 10/12/12. She stated it was hot. I advised patient to take TYLENOL for pain and see MD ASAP.
Sore right arm on first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore right arm on first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore right arm on first dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Sore right arm on first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-097941 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-097941:dose 2 case
Reported as red, itchy, hard welp bigger than half dollar.  Arm tenderness.
At 4 month well visit, (on 9/29/09) the second dose of Rotavirus was not given due to mothers report that patient experienced abdominal cramping and pain after the administration of the first dose of Rotavirus on 8/4/09.
Pain in chest- emergency room-8pm- hospital Shortness of breath  Swelling in hands, feet, body. Painful.  Sleeplessness
Developed a metallic taste in the mouth 20 minutes after injection followed by dry mouth.  symptoms seem to get worse after eating, they have not gotten any better since the shot.
On approximately April 26, 2021, (3 months after receiving the second Pfizer vaccine on 2/9/21), I woke up with painful, swollen joints in both hands.  Saw my primary physician who ordered a RA panel.  ANA was positive with a titer of 1:320.  Referred me to RA physician.   First available appointment was in 3 months.  Was in constant pain for 3 months.  Primary physician was able to prescribe Meloxicam and then Diclophenac? for pain while I waited.  During this time I also developed Sciatica in right leg and fell twice in one day.  Leg just gave out while walking.  Was not able to do much at all during this time as my hand joints were too painful to open jars, proper hygiene, day to day house cleaning or cooking activities.  I had to have people take me to doctor appointments, etc. as I was scared to drive or walk because of the weakness in right leg.
Following immun rt deltoid painful & very swollen (site of DTP inject); Advised to apply ice packs & see MD if swelling won't subside;
Baby started with a fever later that afternoon and has continued with fever through to today.  Temp max 103 - does respond to tylenol but comes straight back when tylenol wears off.  Hives covering the whole body.  baby irritable and fussy - reduced appetite.
the patient had received 4 total Pfizer vaccinations prior to symptom onset and the Positive test result; the patient had received 4 total Pfizer vaccinations prior to symptom onset and the Positive test result; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A 54-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and in Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 53 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Jun2022, outcome "recovering" and all described as "the patient had received 4 total Pfizer vaccinations prior to symptom onset and the Positive test result". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (27Jun2022) Positive; SARS-CoV-2 test: (28Jun2022) Positive. Clinical course: On 27Jun2022 patient began feeling symptoms of fever, fatigue, headache, vision disturbance (everything looks smooth), sore throat and coughing. On 28Jun2022 patient felt worse and took an at home Covid test which was Positive. Patient wife told her mother-in-law about the symptoms. The mother-in-law informed on 30Jun2022 of the symptoms and positive Covid test results. This event was being reported as a Lack of Effect since the patient had received 4 total Pfizer vaccinations prior to symptom onset and the Positive test result. The 4th shot (second booster) was given some time in Mar2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-JUN-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine was exposed to following separate temperature excursions: first lasting for 712 hours, with the lowest recorded temperature of 34 degrees Fahrenheit and the second lasting for 168 hours, with the lowest recorded temperature of 32 degrees Fahrenheit. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Soreness came on in a couple of hours in left deltoid. The intensity vacillates from mild to severe pain. Restricting my use of the arm. This has been 33 days and counting.
Patient came into office fussy.  Alternating with tired, no source identified, patient was sent out with symptomatic care.  Parents called the next day with bloody stools and sent to ED.  Patient diagnosed with intussuception - Air Enema failed to reduce. Surgery showed 4cm of necrotic bowel. Primary anastomosed, Meckel's found at time of surgery. As given by MD 04/11/07-DC Summary received for DOS 3/11-3/17/07-DX Intussusception. Presented with emesis and bright red blood per rectum. Laparotomy and ileal resection and subclavian placement. Recovered and discharged.
Patient presented at ER 11/07/08 with shortness of breath, swelling of lips, mouth, numbness of hands and face. She responded to 50 mg oral BENADRYL and was released. 12/02/08 and 12/03/08 she presented to ER with similar signs/symptoms but also hives, "croupy" cough she was given BENADRYL 50 mg by mouth then EPINEPHRINE 1:1000 0.3 ml sq and PREDISONE. Symptoms improved and she was released.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2022 at 8:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Feb-2022 at 8:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Ethnicity was reported as White. No concomitant medication was reported by reporter.  Vaccine was in thaw state (2 to 8 degree Celsius) from about 20-Dec-2021. No treatment medication was reported by reporter.; Sender's Comments:  MOD-2022-542869:Master Case
Per patient said that 1 week after her first dose, patient said her lymph nodes in her left armpit hurt. Patient said they went away in a couple of days.
Pt was admitted to hospital from the ED for a fever on 4/3/21 after receiving the second dose of vaccine on 3/19/2021. Per guidelines, all hospitalizations are reported
viral meningitis, losing function in his legs; viral meningitis, losing function in his legs; headache; dizziness; fatigue; nausea; weak; This is a spontaneous report from a contactable consumer. A 66-year-old male patient received their first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient kept having very very bad headaches, dizziness, fatigue, nausea, for several days about a whole week and experienced "viral meningitis, losing function in his legs and he's still weak and having issues". The outcome of the events was unknown.  information on the LOT/Batch number has been requested
Warm red mound at injection site, painful if bumped, but arm ok to use. Lasted 3 days, then needle site itchy for 3 days
No adverse effects reported; one male infant received improperly stored ROTATEQ; This spontaneous report was received from a physician, referring to a 10 weeks old male patient. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported.   On 12-SEP-2019, the patient was vaccinated with an improperly stored dose of  Rotavirus Vaccine, Live, Oral, Pentavalent  (ROTATEQ) orally, lot # R002805, expiration date 23-SEP-2019 , for prophylaxis (strength, dose and frequency were not reported).   The temperature excursion was above 9 Centigrade degrees (°C) (17.4°C) during 24 hours, below 36°F / 2°C (-0.3, multiple) for 11 hours and 17 minutes, 2°C to 8°C (1.6°C) for 2 hours and 52 minutes. A previous temperature excursion was not reported. A digital data logger was involved. No adverse effects were reported. The physician stated that no doses of Rotavirus Vaccine, Live, Oral, Pentavalent  (ROTATEQ) were administered since 12-SEP-2019 through 02-OCT-2019. Expired vaccines were taken out of the formulary.
I woke up with severe right sided abdominal pain. I went to the ER and I had a CT with contrast and ultrasound and my right ovary was significantly larger than an ovarian cyst that had ruptured and there were 2 still intact. They also did blood work and a vaginal swab. The blood work came back with elevated white blood cells and the swab came back negative. I followed up with the doctor on Friday and she placed me on estrogen hormone treatment and an antibiotic for infection. I also experience swelling on my lymph nodes by my ears and my jaw, that was very painful for like 3 days. My face was really swollen. I still have some residual pain. They are doing an ultrasound in about 4 weeks.
pt recvd vax & found to have fever of 101 R-repeat 101.7 R; found to have lt OM & given ATB; 8 hrs later pt had a brief tonic clonic sz; brought to ER t103.8 R;
pt recvd vax & became listless, weak, sleepy, threw-up; seen by MD; hosp for observation;
I received the shot around noon on Tues March 16.  I was fine until 3am Wed March 17 when I woke up general body soreness and sweats.  I had Covid in March 2020 and the feeling was similar without the coughing and much shorter timeframe.  That continued until about 3am on Thursday March 18 when I thought I was almost back to normal.   When I woke up at 6am I thought I was ok but then I realized I had a lump under my left armpit on my side seemingly like my lymph node is swollen.  That continues as I write this at 341pm on Friday March 19.  I also developed hives on my right bicep and on my left and right buttocks and left and right hamstrings.  this is itchy.  I no longer have the soreness, sweating or fatigue but i have the swollen and what seems to be allergic reaction symptoms of hives.
20 minutes after vaccine I had a very strong metallic taste in mouth. It had lessen by the time I got home. I had achyness, chills, nausea. My lymph nodes on my collar bone is swollen. My lymph node on my collar bone is about the size of a walnut.
Patient developed swelling and redness to the injection site  the day of vaccination.  This increased both in extent and redness over the next  3 days.  He did not have any other associated symptoms: no fever, generalized rash, difficulty breathing, swelling of the lips or tongue, or difficulty ambulating.  At its largest, the redness measured approximately 9 x 10cm.  Eight days after the injection his left thigh measured 2.5 cm larger in circumference compared to the right.
Fever (100.7), headache, chills, sweating, Muscle pain, Sever joint pain all over body.  Left me unable to sleep for 2 nights because of pain and chills.   Sever Pain and redness and swelling around injection site, nausea, fatigue, lymph mode pain and swelling in neck area of left side where injection was given. Generally felt very ill as if I had seasonal flu.